within Pharmacolibrary.Drugs.ATC.N;

model N06BA05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 1.3333333333333334e-06,
    adminDuration  = 600,
    adminMass      = 75 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0012,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00385,
    Tlag           = 0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N06BA05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Pemoline is a central nervous system stimulant formerly used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Its use has largely been discontinued and it is no longer widely approved due to concerns over its potential for hepatotoxicity.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data from healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Vermeulen, NP, et al., &amp; Breimer, DD (1979). Pharmacokinetics of pemoline in plasma, saliva and urine following oral administration. <i>British journal of clinical pharmacology</i> 8(5) 459–463. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1979.tb01026.x&quot;>10.1111/j.1365-2125.1979.tb01026.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/508551/&quot;>https://pubmed.ncbi.nlm.nih.gov/508551</a></p></li><li><p>Sallee, F, et al., &amp; Bates, T (1985). Oral pemoline kinetics in hyperactive children. <i>Clinical pharmacology and therapeutics</i> 37(6) 606–609. DOI:<a href=&quot;https://doi.org/10.1038/clpt.1985.96&quot;>10.1038/clpt.1985.96</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4006361/&quot;>https://pubmed.ncbi.nlm.nih.gov/4006361</a></p></li><li><p>Igwe, OJ, &amp; Blake, JW (1983). The pharmacokinetics, plasma protein binding and time response relationships of 2-amino-5-phenyl-2-oxazolin-4-one (pemoline) in the horse. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 11(2) 120–125. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6133715/&quot;>https://pubmed.ncbi.nlm.nih.gov/6133715</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N06BA05;
